The Role of IL-10 in Regulating Inflammatory Pathways and Cancer Risk

Interleukin-10 (IL-10) is an important anti-inflammatory cytokine that plays a crucial role in regulating immune responses by preventing the immune system from overreacting. It maintains immune homeostasis by suppressing the production of pro-inflammatory cytokines, thus reducing excessive inflammation. This paper explores the genetic variations and biological mechanisms associated with IL-10, focusing on how these factors influence cancer risk and tumor development. Research from genetics, cell biology, and clinical studies reveals that IL-10 has complex, dual roles in cancer. IL-10 plays a dual role in cancer biology, it mitigates chronic inflammation, potentially decreasing the likelihood of DNA damage and tumorigenesis. Conversely, IL-10 may foster an immunosuppressive milieu that enables tumor cells to escape immune surveillance, thus facilitating cancer advancement under specific circumstances. These paradoxical functions highlight IL-10’s significance in both cancer prevention and progression. The findings suggest that IL-10 could serve as a valuable therapeutic target for cancer treatment and as a biomarker for identifying inflammation-related cancers. Understanding IL-10’s dual roles not only provides new insights into the mechanisms of cancer development but also underscores its potential in developing innovative cancer therapies and improving immune system regulation.